Eosinophilic GI Diseases Beyond the Esophagus
Where Have We Been and Where Are We Going?
TUESDAY, AUGUST 11, 2020 | 7:00 PM EDT
    LIVE Virtual Symposium

    Participants can access this live virtual event on Tuesday, August 11, from 7:00 PM - 8:30 PM EDT.

    Activity Overview

    Eosinophilic gastrointestinal diseases (EGIDs) are serious, chronic, inflammatory digestive disorders that affect both children and adults. Lengthy diagnostic delays are common in EGIDs and they often result in disease progression and missed treatment opportunities. In this virtual, interactive CME event, 3 experts will discuss the epidemiology, pathophysiology, clinical presentation, and diagnosis of EGIDs. They will also review pharmacologic and nonpharmacologic treatments for EGIDs, including emerging therapies that target specific inflammatory cytokines and cells implicated in EGID pathogenesis and progression.

    Speakers
    • Gary W. Falk, MD, MS, AGAF
      MODERATOR
      Professor of Medicine
      Division of Gastroenterology
      Perelman School of Medicine
      University of Pennsylvania
      Philadelphia, Pennsylvania
    • Nirmala Gonsalves, MD
      PANELIST
      Professor of Medicine
      Division of Gastroenterology and Hepatology
      The Feinberg School of Medicine
      Northwestern University
      Chicago, Illinois
    • Sandeep Gupta, MD, AGAF
      PANELIST
      Medical Director for Research
      Community Health Network
      Attending Pediatric Gastroenterologist
      Indiana University/Riley Hospital for Children
      Indianapolis, Indiana
    Program Tuesday, August 11, 2020
    • 7:00 PM
    • Welcome and Introductions
      Gary W. Falk, MD, MS, AGAF
    • 7:05 PM
    • Overview of EGIDs
      Gary W. Falk, MD, MS, AGAF
    • 7:20 PM
    • Diagnosing EGIDs in Practice
      Sandeep Gupta, MD, AGAF
    • 7:40 PM
    • Management of EGIDs Beyond the Esophagus: Where Are We Now?
      Nirmala Gonsalves, MD
    • 7:55 PM
    • Emerging Therapies for EGIDs: Where Are We Going?
      Nirmala Gonsalves, MD
    • 8:15 PM
    • Concluding Remarks and Audience Q&A
    • 8:30 PM
    • Adjourn
    Learning Objectives
    Upon completion of this activity, participants will:
    • Have increased knowledge regarding the
      • Pathogenesis of EGIDs
      • Steps for diagnosis of EGIDs
      • Clinical data on emerging therapies for EGIDs
    • Have greater competence related to
      • Selecting treatments for patients with EGIDs
    Target Audience
    This activity is intended for gastroenterologists and other clinicians who manage patients with EGIDs.
    Goal Statement
    The goal of this activity is to improve the recognition, diagnosis, and management of patients with EGIDs.
    Credits Available
    • 1.50
    • For Physicians
    The AGA Institute designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    • For Nurses
    Awarded 1.50 contact hour(s) of continuing nursing education for RNs and APNs.
    Accreditation Statement
    The American Gastroenterological Association (AGA) Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Your home!
    Online
    Presented through a collaboration between American Gastroenterological Association (AGA) and Medscape Education.
    Supported by an independent educational grant from
    Allakos